HDAC2 and breast cancer: The results of the current study demonstrated that there was an inverse relationship between the expression levels of miR-489-3p and its direct target HDAC2 in BC, and that the miR-489-3p/HDAC2 axis served a role in the regulation of BC development and/or progression.